Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Nebivolol/rosuvastatin - Elyson Pharmaceutical

Next Previous
X
Search
Drug Profile

Nebivolol/rosuvastatin - Elyson Pharmaceutical

Alternative Names: EL-1401; Rosuvastatin/nebivolol - Elyson Pharmaceutical

Latest Information Update: 30 Sep 2020

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Elyson Pharm
  • Class Antihyperlipidaemics; Antihypertensives; Benzopyrans; Ethanolamines; Fluorobenzenes; Heart failure therapies; Pyrimidines; Small molecules; Sulfonamides
  • Mechanism of Action Beta 1 adrenergic receptor antagonists; HMG-CoA reductase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Hyperlipidaemia; Hypertension

Most Recent Events

  • 30 Sep 2020 Nebivolol/rosuvastatin - Elyson Pharmaceutical is still in phase III trial for Hyperlipidaemia and Hypertension in South Korea (PO) (Elyson Pharmaceutical pipeline, September 2020)
  • 14 Jan 2020 Elyson Pharmaceutical completes a phase III trial in Hyperlipidaemia and Hypertension in South Korea (PO) (KCT0002148)
  • 31 Aug 2019 Launched for Hyperlipidaemia in South Korea (PO) (Elyson Pharmaceutical pipeline, July 2022)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top